Treatment of the most common respiratory infections in children
Abstract
Acute respiratory infections are the most common group of infective diseases in the pediatric population. Although the improvement of health care and vaccination program has led to a significant reduction in the incidence of certain respiratory infections, the combination of a high prevalence in vulnerable pediatric categories and uncritical prescription of antibiotics, due to the inability to adequately distinguish between viruses and bacterial etiology, still represents a significant challenge for the public health system. In order to promote rational antibiotic therapy with an overall improvement of both diagnostic and therapeutic principles, acute respiratory diseases have been the subject of consideration in numerous publications and national guidelines. Nonspecific clinical manifestations with pathogen heterogeneity and both anatomical and physiological characteristics of the child's respiratory system during growth and development have created the need for individualized therapy. Since the guidelines emphasize the undoubtful and crucial benefits of symptomatic therapy (e.g. analgesics in acute otitis media, supplemental oxygen in lower respiratory tract infections with hypoxemia), the use of antibiotics and corticosteroids is indicated in selected cases with a severe clinical picture. The choice of antibiotic depends on the clinical condition, presumed causative agent, and local epidemiologic circumstances. Respiratory support (oxygen therapy and/or artificial ventilation) is reserved for inpatient treatment of cases with a particularly severe clinical picture and associated complications.
References
Pelemis M, editor. Racionalna upotreba antibiotika. Nacionalni vodic dobre klinicke prakse [Internet]. Beograd: Ministarstvo zdravlja Republike Srbije; 2018 [cited 2022 Jun 24]. Available from: https://www.zdravlje.gov.rs/view_file.php?file_id=527&cache=sr.
Bozic B, Bajcetic M. Use of antibiotics in paediatric primary care settings in Serbia. Arch Dis Child. 2015;100(10):966-9.
Turner RB. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol. 1997;78(6):531-9; quiz 539-40.
Rhinovirus (RV) Infection (Common Cold): Practice Essentials, Background, Pathophysiology [Internet]. 2021 Oct 16 [cited 2022 Jun 24]. Available from: https://emedicine.medscape.com/article/227820-overview#a4.
Jaume F, Quintó L, Alobid I, Mullol J. Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study). BMJ Open. 2018;8(1):e018788.
Stjärne P, Odebäck P, Ställberg B, Lundberg J, Olsson P. High costs and burden of illness in acute rhinosinusitis: real-life treatment patterns and outcomes in Swedish primary care. Prim Care Respir J. 2012;21(2):174-9; quiz 10p following 179.
Jaume F, Valls-Mateus M, Mullol J. Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020. Curr Allergy Asthma Rep. 2020;20(7):28.
Johnson DA, Hricik JG. The pharmacology of alpha-adrenergic decongestants. Pharmacotherapy. 1993;13(6 Pt 2):110S-115S; discussion 143S-146S.
Deckx L, De Sutter AI, Guo L, Mir NA, van Driel ML. Nasal decongestants in monotherapy for the common cold. Cochrane Database Syst Rev. 2016;10(10):CD009612.
Gelotte CK, Albrecht HH, Hynson J, Gallagher V. A Multicenter, Randomized, Placebo-Controlled Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold. J Clin Pharmacol. 2019;59(12):1573-1583.
De Sutter AI, Eriksson L, van Driel ML. Oral antihistamine-decongestant-analgesic combinations for the common cold. Cochrane Database Syst Rev. 2022;1(1):CD004976.
McKean M, Ducharme F. Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database Syst Rev. 2000;2000(2):CD001107.
Panickar J, Lakhanpaul M, Lambert PC, Kenia P, Stephenson T, Smyth A, et al. Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med. 2009;360(4):329-38.
Bernard DW, Goepp JG, Duggan AK, Serwint JR, Rowe PC. Is oral albuterol effective for acute cough in non-asthmatic children? Acta Paediatr. 1999;88(4):465-7.
Paul IM, Yoder KE, Crowell KR, Shaffer ML, McMillan HS, Carlson LC, et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics. 2004;114(1):e85-90.
Paul IM, Beiler JS, King TS, Clapp ER, Vallati J, Berlin CM Jr. Vapor rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms. Pediatrics. 2010;126(6):1092-9.
Kenia P, Houghton T, Beardsmore C. Does inhaling menthol affect nasal patency or cough? Pediatr Pulmonol. 2008;43(6):532-7.
King D, Mitchell B, Williams CP, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015;(4):CD006821.
Slapak I, Skoupá J, Strnad P, Horník P. Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children. Arch Otolaryngol Head Neck Surg. 2008;134(1):67-74.
Arroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2005;(3):CD000247.
Wald ER, Applegate KE, Bordley C, Darrow DH, Glode MP, Marcy SM, et al. American Academy of Pediatrics. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics. 2013;132(1):e262-80.
Sykes EA, Wu V, Beyea MM, Simpson MTW, Beyea JA. Pharyngitis: Approach to diagnosis and treatment. Can Fam Physician. 2020;66(4):251-257.
Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Infectious Diseases Society of America. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):e86-102. Erratum in: Clin Infect Dis. 2014;58(10):1496. Dosage error in article text.
ESCMID Sore Throat Guideline Group, Pelucchi C, Grigoryan L, Galeone C, Esposito S, Huovinen P, et al. Guideline for the management of acute sore throat. Clin Microbiol Infect. 2012;18 Suppl 1:1-28.
Matthys J, De Meyere M, van Driel ML, De Sutter A. Differences among international pharyngitis guidelines: not just academic. Ann Fam Med. 2007;5(5):436-43.
Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis [Internet]. [cited 2022 Jun 24]. Available from:
https://www.ahajournals.org/doi/epub/10.1161/CIRCULATIONAHA.109.191959.
Glassock RJ, Alvarado A, Prosek J, Hebert C, Parikh S, Satoskar A, et al. Staphylococcus-related glomerulonephritis and poststreptococcal glomerulonephritis: why defining "post" is important in understanding and treating infection-related glomerulonephritis. Am J Kidney Dis. 2015;65(6):826-32.
Bateman E, Mansour S, Okafor E, Arrington K, Hong BY, Cervantes J. Examining the Efficacy of Antimicrobial Therapy in Preventing the Development of Postinfectious Glomerulonephritis: A Systematic Review and Meta-Analysis. Infect Dis Rep. 2022;14(2):176-183.
Roberts JR. Symptomatic Treatment for Acute Pharyngitis. Emerg Med News. 2001;23(1):11–2.
van Driel ML, De Sutter AI, Habraken H, Thorning S, Christiaens T. Different antibiotic treatments for group A streptococcal pharyngitis. Cochrane Database Syst Rev. 2016;9(9):CD004406. Update in: Cochrane Database Syst Rev. 2021;3:CD004406.
Chiappini E, Regoli M, Bonsignori F, Sollai S, Parretti A, Galli L, et al. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther. 2011;33(1):48-58.
Kalra MG, Higgins KE, Perez ED. Common Questions About Streptococcal Pharyngitis. Am Fam Physician. 2016;94(1):24-31. Erratum in: Am Fam Physician. 2017;95(7):414.
Altamimi S, Khalil A, Khalaiwi KA, Milner RA, Pusic MV, Al Othman MA. Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children. Cochrane Database Syst Rev. 2012;(8):CD004872.
El Hennawi DED, Geneid A, Zaher S, Ahmed MR. Management of recurrent tonsillitis in children. Am J Otolaryngol. 2017;38(4):371-374.
Vanoni F, Theodoropoulou K, Hofer M. PFAPA syndrome: a review on treatment and outcome. Pediatr Rheumatol Online J. 2016;14(1):38.
Baugh RF, Archer SM, Mitchell RB, Rosenfeld RM, Amin R, Burns JJ, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: tonsillectomy in children. Otolaryngol Head Neck Surg. 2011;144(1 Suppl):S1-30.
Martínez Pascual P, Pinacho Martinez P, Friedlander E, Martin Oviedo C, Scola Yurrita B. Peritonsillar and deep neck infections: a review of 330 cases. Braz J Otorhinolaryngol. 2018;84(3):305-310.
Leibovitz E, Greenberg D. Acute otitis media in children: current epidemiology, microbiology, clinical manifestations, and treatment. Chang Gung Med J. 2004;27(7):475-88.
Danishyar A, Ashurst JV. Acute Otitis Media. 2022 Jan 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan– [cited 2022 Jun 24]. PMID: 29262176.
Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3):e964-99. Erratum in: Pediatrics. 2014;133(2):346. Dosage error in article text.
Kraemer MJ, Richardson MA, Weiss NS, Furukawa CT, Shapiro GG, Pierson WE, et al. Risk factors for persistent middle-ear effusions. Otitis media, catarrh, cigarette smoke exposure, and atopy. JAMA. 1983;249(8):1022-5.
Glasziou PP, Del Mar CB, Sanders SL, Hayem M. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2004;(1):CD000219. Update in: Cochrane Database Syst Rev. 2013;1:CD000219.
Burke P, Bain J, Robinson D, Dunleavey J. Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ. 1991;303(6802):558-62.
Coleman C, Moore M. Decongestants and antihistamines for acute otitis media in children. Cochrane Database Syst Rev. 2008;(3):CD001727. Update in: Cochrane Database Syst Rev. 2011;(3):CD001727.
Chiappini E, Ciarcià M, Bortone B, Doria M, Becherucci P, Marseglia GL, et al. Italian Panel for the Management of Acute Otitis Media in Children. Updated Guidelines for the Management of Acute Otitis Media in Children by the Italian Society of Pediatrics: Diagnosis. Pediatr Infect Dis J. 2019;38(12S Suppl):S3-S9.
Spiro DM, Tay K, Arnold DH, Dziura JD, Baker MD, Shapiro ED. Wait-and-See Prescription for the Treatment of Acute Otitis Media: A Randomized Controlled Trial. JAMA. 2006;296(10):1235–1241.
Thomas JP, Berner R, Zahnert T, Dazert S. Acute otitis media--a structured approach. Dtsch Arztebl Int. 2014;111(9):151-9; quiz 160. Erratum in: Dtsch Arztebl Int. 2016;113(7):113.
Hayashi T, Kitamura K, Hashimoto S, Hotomi M, Kojima H, Kudo F, et al. Clinical practice guidelines for the diagnosis and management of acute otitis media in children-2018 update. Auris Nasus Larynx. 2020;47(4):493-526.
Danishyar A, Ashurst JV. Acute Otitis Media. 2022 Jan 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan– [cited 2022 Jun 24]. PMID: 29262176.
Acute Otitis Media Treatment & Management: Approach Considerations, Antimicrobial Therapy, Tympanocentesis, Myringotomy, and Tympanostomy [Internet]. 2021 Dec 27 [cited 2022 Jun 24]. Available from: https://emedicine.medscape.com/article/859316-treatment#d8.
Benchafai I, Moumni M, Ouraini S, Errami N, Hemmaoui B, Benariba F. Medial migration of the tympanostomy tube: what is the optimal management option? Pan Afr Med J. 2019;34:216.
Hoberman A, Marchant CD, Kaplan SL, Feldman S. Treatment of acute otitis media consensus recommendations. Clin Pediatr (Phila). 2002;41(6):373-90.
Brake MK, Jewer K, Flowerdew G, Cavanagh JP, Cron C, Hong P. Tympanocentesis results of a Canadian pediatric myringotomy population, 2008 to 2010. J Otolaryngol Head Neck Surg. 2012;41(4):282-7.
Rihkanen H, Rönkkö E, Nieminen T, Komsi KL, Räty R, Saxen H, et al. Respiratory viruses in laryngeal croup of young children. J Pediatr. 2008;152(5):661-5. Erratum in: J Pediatr. 2008;153(1):151. Anne, Lahtinen [corrected to Beng, Anne Lahtinen].
Bjornson CL, Johnson DW. Croup in children. CMAJ. 2013;185(15):1317-23.
Rosychuk RJ, Klassen TP, Metes D, Voaklander DC, Senthilselvan A, Rowe BH. Croup presentations to emergency departments in Alberta, Canada: a large population-based study. Pediatr Pulmonol. 2010;45(1):83-91.
Ortiz-Alvarez O. Acute management of croup in the emergency department. Paediatr Child Health. 2017;22(3):166-173.
Croup Treatment & Management: Approach Considerations, Corticosteroids, Adrenaline [Internet]. 2020 Mar 23 [cited 2022 Jun 24]. Available from: https://emedicine.medscape.com/article/962972-treatment#d10.
Russell KF, Liang Y, O'Gorman K, Johnson DW, Klassen TP. Glucocorticoids for croup. Cochrane Database Syst Rev. 2011;(1):CD001955. Update in: Cochrane Database Syst Rev. 2018;8:CD001955.
Bjornson CL, Klassen TP, Williamson J, Brant R, Mitton C, Plint A, et al. Pediatric Emergency Research Canada Network. A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med. 2004;351(13):1306-13.
Johnson DW, Jacobson S, Edney PC, Hadfield P, Mundy ME, Schuh S. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med. 1998;339(8):498-503.
Geelhoed GC, Macdonald WB. Oral and inhaled steroids in croup: a randomized, placebo-controlled trial. Pediatr Pulmonol. 1995;20(6):355-61.
Kairys SW, Olmstead EM, O'Connor GT. Steroid treatment of laryngotracheitis: a meta-analysis of the evidence from randomized trials. Pediatrics. 1989;83(5):683-93.
Donaldson D, Poleski D, Knipple E, Filips K, Reetz L, Pascual RG, et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized, double-blind trial. Acad Emerg Med. 2003;10(1):16-21.
Rittichier KK, Ledwith CA. Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics. 2000;106(6):1344-8.
Somani R, Evans MF. Role of glucocorticoids in treating croup. Can Fam Physician. 2001;47:733-5.
Husby S, Agertoft L, Mortensen S, Pedersen S. Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Arch Dis Child. 1993;68(3):352-5.
Cetinkaya F, Tüfekçi BS, Kutluk G. A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. Int J Pediatr Otorhinolaryngol. 2004;68(4):453-6.
Johnson DW. Croup. BMJ Clin Evid. 2014;2014:0321.
Waisman Y, Klein BL, Boenning DA, Young GM, Chamberlain JM, O'Donnell R, et al. Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup). Pediatrics. 1992;89(2):302-6.
Prendergast M, Jones JS, Hartman D. Racemic epinephrine in the treatment of laryngotracheitis: can we identify children for outpatient therapy? Am J Emerg Med. 1994;12(6):613-6.
Savić N, Janković B, Minić P, Vasiljević Z, Sovtić A, Pejić K, et al. Clinical characteristics of respiratory syncytial virus infection in neonates and young infants. Vojnosanit Pregl. 2011;68(3):220-4.
Øymar K, Skjerven HO, Mikalsen IB. Acute bronchiolitis in infants, a review. Scand J Trauma Resusc Emerg Med. 2014;22:23.
Ghazaly M, Nadel S. Characteristics of children admitted to intensive care with acute bronchiolitis. Eur J Pediatr. 2018;177(6):913-920.
Nagakumar P, Doull I. Current therapy for bronchiolitis. Arch Dis Child. 2012;97(9):827-30.
Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Lancet. 2000;355(9202):451-5. Erratum in: Lancet. 2000;355(9209):1104.
Dornelles CT, Piva JP, Marostica PJ. Nutritional status, breastfeeding, and evolution of Infants with acute viral bronchiolitis. J Health Popul Nutr. 2007;25(3):336-43.
Gadomski AM, Brower M. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2010;(12):CD001266. Update in: Cochrane Database Syst Rev. 2014;6:CD001266.
Wainwright C. Acute viral bronchiolitis in children- a very common condition with few therapeutic options. Paediatr Respir Rev. 2010;11(1):39-45; quiz 45.
Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, et al. American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134(5):e1474-502. Erratum in: Pediatrics. 2015;136(4):782.
Parker MJ, Allen U, Stephens D, Lalani A, Schuh S. Predictors of major intervention in infants with bronchiolitis. Pediatr Pulmonol. 2009;44(4):358-63.
Zorc JJ, Hall CB. Bronchiolitis: recent evidence on diagnosis and management. Pediatrics. 2010;125(2):342-9.
Mandelberg A, Amirav I. Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Pediatr Pulmonol. 2010;45(1):36-40.
Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2008;(4):CD006458. Update in: Cochrane Database Syst Rev. 2013;7:CD006458.
Hasegawa K, Tsugawa Y, Brown DF, Mansbach JM, Camargo CA Jr. Trends in bronchiolitis hospitalizations in the United States, 2000-2009. Pediatrics. 2013;132(1):28-36.
Mussman GM, Parker MW, Statile A, Sucharew H, Brady PW. Suctioning and length of stay in infants hospitalized with bronchiolitis. JAMA Pediatr. 2013;167(5):414-21.
Plint AC, Johnson DW, Patel H, Wiebe N, Correll R, Brant R, et al. Pediatric Emergency Research Canada (PERC). Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med. 2009;360(20):2079-89.
Patel H, Platt R, Lozano JM, Wang EE. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2004;(3):CD004878. Update in: Cochrane Database Syst Rev. 2008;(1):CD004878.
Blom D, Ermers M, Bont L, van Aalderen WM, van Woensel JB. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database Syst Rev. 2007;(1):CD004881. Update in: Cochrane Database Syst Rev. 2011;(1):CD004881.
Dafydd C, Saunders BJ, Kotecha SJ, Edwards MO. Efficacy and safety of high flow nasal oxygen for children with bronchiolitis: systematic review and meta-analysis. BMJ Open Respir Res. 2021;8(1):e000844.
Wolfler A, Raimondi G, Pagan de Paganis C, Zoia E. The infant with severe bronchiolitis: from high flow nasal cannula to continuous positive airway pressure and mechanical ventilation. Minerva Pediatr. 2018;70(6):612-622.
Seliem W, Sultan AM. Heliox delivered by high flow nasal cannula improves oxygenation in infants with respiratory syncytial virus acute bronchiolitis. J Pediatr (Rio J). 2018;94(1):56-61.
Seliem W, Sultan AM. ¿Mejora la administración de helio mediante cánula nasal de bajo flujo la dificultad respiratoria en lactantes con bronquiolitis aguda por virus respiratorio sincitial? Estudio aleatorizado controlado [Does heliox administered by low-flow nasal cannula improve respiratory distress in infants with respiratory syncytial virus acute bronchiolitis? A randomized controlled trial]. An Pediatr (Engl Ed). 2019;90(1):3-9. (in Spanish).
Ebeledike C, Ahmad T. Pediatric Pneumonia. 2022 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan– [cited 2022 Jun 24]. PMID: 30725625.
Gupta GR. Tackling pneumonia and diarrhoea: the deadliest diseases for the world's poorest children. Lancet. 2012;379(9832):2123-4.
Jadavji T, Law B, Lebel MH, Kennedy WA, Gold R, Wang EE. A practical guide for the diagnosis and treatment of pediatric pneumonia. CMAJ. 1997;156(5):S703-11.
Handy LK, Bryan M, Gerber JS, Zaoutis T, Feemster KA. Variability in Antibiotic Prescribing for Community-Acquired Pneumonia. Pediatrics. 2017;139(4):e20162331.
Reckziegel M, Weber-Osel C, Egerer R, Gruhn B, Kubek F, Walther M, et al. Viruses and atypical bacteria in the respiratory tract of immunocompromised and immunocompetent patients with airway infection. Eur J Clin Microbiol Infect Dis. 2020;39(8):1581-1592. Erratum in: Eur J Clin Microbiol Infect Dis. 2022;41(2):339.
Salzer HJF, Schäfer G, Hoenigl M, Günther G, Hoffmann C, Kalsdorf B, et al. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia. Respiration. 2018;96(1):52-65.
Matera MG, Rogliani P, Ora J, Cazzola M. Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents. Expert Opin Pharmacother. 2018;19(18):2043-2053.
Revised WHO Classification and Treatment of Pneumonia in Children at Health Facilities: Evidence Summaries. Geneva: World Health Organization, 2014. PMID: 25535631.
Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, et al. Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25-76.
Masters IB, Isles AF, Grimwood K. Necrotizing pneumonia: an emerging problem in children? Pneumonia (Nathan). 2017;9:11.
Canty E, Carnahan B, Curley T, Anususinha E, Hamdy RF, Ericson JE. Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections. Pediatr Infect Dis J. 2021;40(5):429-433.
Tamma PD, Cosgrove SE. Duration of antibiotic therapy for community-acquired pneumonia in children. Clin Infect Dis. 2012;54(6):883-4; author reply 885.
Barratt S, Bielicki JA, Dunn D, Faust SN, Finn A, Harper L, et al. Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT. Health Technol Assess. 2021;25(60):1-72.
Group A Streptococcal (GAS) Infections Treatment & Management: Approach Considerations, Pharmacologic Therapy, Monitoring [Internet]. 2021 Oct 17 [cited 2022 Jun 24]. Available from: https://emedicine.medscape.com/article/228936-treatment#d9.
